Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_assertion type Assertion NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_head.
- NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_assertion description "[The standard treatments for chronic lymphocytic leukemia (CLL) include the alkylating agent chlorambucil (CLB) and the nucleoside analog fludarabine (F-ara-AMP, Flu).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_provenance.
- NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_assertion evidence source_evidence_literature NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_provenance.
- NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_assertion SIO_000772 14614459 NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_provenance.
- NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_assertion wasDerivedFrom befree-20150227 NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_provenance.
- NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_assertion wasGeneratedBy ECO_0000203 NP247315.RARnNS61zhJrkv1i59Y1wAYUjKQyoPFk5xvb9aDMoMEwY130_provenance.